BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago Molten Ventures Executes Share Buyback Program Voting Rights Share Buyback Financial Disclosure Molten Ventures Stockbrokers
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago Molten Ventures lance un programme de rachat d'actions Rachat D'actions Droit De Vote Divulgation Financière Entreprises En Fusion Courtiers En Valeurs Mobilières
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago Fuller, Smith & Turner PLC Executes Share Buyback Regulatory Compliance Share Buyback Treasury Shares Stock Exchange Fuller’s
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago Fuller, Smith & Turner PLC procède à un rachat d'actions Actions Propres Rachat D'actions Bourse Conformité Réglementaire Fuller
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago Clearway Capital Calls for Transparency in GZO AG Creditor Committee Proposal Transparency GZO AG Clearway Capital Trustee Replacement Creditor Committee
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago Clearway Capital appelle à la transparence dans la proposition du comité des créanciers de GZO AG Transparence Comité Des Créanciers GZO AG Clearway Capital Remplacement Du Fiduciaire
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago Gerresheimer AG Appoints Wolf Lehmann as New CFO CFO Appointment Management Transition Gerresheimer AG Wolf Lehmann Dr. Bernd Metzner
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago Gerresheimer AG nomme Wolf Lehmann au poste de directeur financier Transition Managériale Gerresheimer AG Nomination Du Directeur Financier Wolf Lehmann Dr Bernd Metzner
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago OSE Immunotherapeutics Clarifies Strategy Amid Shareholder Activism Strategic Priorities Legal Proceedings OSE Immunotherapeutics Shareholder Activism Tedopi® And Lusvertikimab
BRIEF published on 08/29/2025 at 08:05, 11 months 17 days ago OSE Immunotherapeutics clarifie sa stratégie face à l'activisme des actionnaires Priorités Stratégiques OSE Immunotherapeutics Activisme Des Actionnaires Procédures Judiciaires Tedopi® Et Lusvertikimab
Published on 08/15/2026 at 00:50, 23 hours 49 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 1 day ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 1 day ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:00, 1 day 1 hour ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 15:05, 9 hours 33 minutes ago Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming
Published on 08/15/2026 at 08:05, 16 hours 33 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 1 day 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/13/2026 at 18:00, 2 days 6 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 4 days 6 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 4 days 6 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 5 days 6 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 5 days 6 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
